The FDA has granted approval for a next-generation Covid vaccine developed by Moderna, albeit with certain restrictions. Recent changes on the CDC’s website reflect a shift in recommendations for pregnant individuals regarding Covid vaccination. While pregnant people are no longer advised to receive the vaccine, the agency continues to stress the importance of Covid boosters during pregnancy. Additionally, the FDA has requested Moderna to conduct a new trial targeting adults aged 50 to 64 to assess the vaccine’s efficacy in this population. A recent commentary in the New England Journal of Medicine by FDA officials highlighted the ongoing debate on the benefits of Covid vaccines for low-risk individuals, emphasizing a future focus on high-risk groups and older adults.
Read more from statnews.com
